The model of 4D CTA-CS combined with BNP is mostly effective in predicting the clinical outcome of AIS when compared with 4D CTA-CS or BNP alone and might determine stroke subtypes (CE or LAA stroke). This evidence concerns the gene NPPB and stroke disorder.